There is no single price for GHK-Cu because cost tracks the product form, the stated concentration, the verified purity, and the intended use, and the spread is wide. Finished topical cosmetics carrying the copper peptide are the most common consumer form and the most relevant to a skincare buyer, while lyophilized research-grade powder occupies a separate, laboratory-use category that is not approved as a dietary supplement or a drug.
GHK-Cu has no single price; finished topical cosmetics commonly run fifteen to sixty dollars per 30 mL bottle, while research-grade powder is sold per milligram for laboratory use and is not approved for human application.
Price ranges separate cleanly along product form, which is why the form a buyer is looking at sets the expectation before any other factor. The cost reality is that serums, creams, and research vials are quoted on different bases entirely, and two products of the same form can still diverge sharply because of concentration, testing, and brand positioning rather than chemistry.
| Product form | Reported price band | Basis noted in the market |
|---|---|---|
| Topical serum (30 mL) | $15 to $60, clustering $25 to $40 | Most widely sold consumer format |
| Cream / moisturizer | $30 to $80 | Bundles added emollients and actives |
| Research vial (50 mg) | ~$20 to $50 | Per-milligram, laboratory use |
| Research vial (100 mg) | ~$60 to $70+ | Purity and supplier reputation drive spread |
| Professional / clinical line | $100+ | Premium positioning, not different chemistry |
Topical serums are reported at fifteen to sixty dollars per 30 mL bottle and creams at thirty to eighty dollars, while lyophilized research vials are priced per milligram at roughly twenty to seventy dollars and clinical-line products exceed one hundred dollars on positioning rather than chemistry.
Pricing by active content is the most meaningful way the market compares options, though it takes a little arithmetic to get there. The economics turn on normalizing away bottle size and concentration: a per-milligram figure exposes what a buyer is actually paying for, which a headline sticker price hides.
Research-grade GHK-Cu powder is commonly listed at roughly forty cents to one dollar per milligram before purity adjustment, and a per-milligram figure is more reliable than headline price because it normalizes away bottle size and concentration.
Two GHK-Cu products can differ in price by a wide margin, and the documented forces behind that spread separate genuine quality from markup. The value verdict is that several of these forces, especially packaging and brand positioning, can dominate consumer pricing while contributing nothing to the chemistry inside.
GHK-Cu price variation is driven by third-party purity verification, supplier reputation, formulation complexity, and packaging or branding, the last of which can dominate consumer pricing while adding nothing to the chemistry, so independent verification rather than price is the better guide to quality.
On a pure per-milligram basis lyophilized research powder is usually cheaper than finished topical cosmetics, but that raw-cost comparison omits the most important distinction, which is regulatory category. The trade-off documented in the market is that the lower powder price does not account for the labor, uncertainty, and safety burden a formulated product resolves.
| Criteria | Research powder | Topical cosmetic |
|---|---|---|
| Per-milligram cost | Lower | Higher |
| Regulatory category | Laboratory use, not for human consumption | Formulated and labeled for topical human use |
| Formulation | User reconstitutes and judges concentration | Stabilized, pH-balanced, ready to use |
| Practical risk | Sterility and stability fall to the user | Resolved by professional formulation |
Lyophilized research powder carries a lower per-milligram cost than finished topical cosmetics but is labeled for laboratory use and not for human consumption, while cosmetic products cost more because they are formulated, stabilized, and labeled for topical human use.
Because GHK-Cu is documented as part of a sustained routine rather than a one-time purchase, the realistic budgeting question is annual rather than per-bottle, and small differences in price or product longevity compound noticeably over twelve months. Ongoing cost depends heavily on product choice, application area, and frequency, but the published ranges can be sketched.
A thirty to forty dollar GHK-Cu serum used once or twice daily on the face lasts about one to two months and runs roughly fifteen to forty dollars monthly, or two hundred to five hundred dollars annually for a single mid-range product, with scalp use raising the figure.
Concentration is the hinge between sticker price and actual value, yet it is frequently underexamined. Commercial topicals span about 0.05 percent to 2 percent, a fortyfold difference in active peptide for the same bottle size, so two products at an identical price can deliver vastly different amounts of active ingredient.
Commercial GHK-Cu topicals range from about 0.05 percent to 2 percent, a fortyfold difference in active peptide for the same bottle size, so a 30 mL serum at 1 percent holds roughly three hundred milligrams while the same bottle at 0.1 percent holds only about thirty.
Quality verification is often what separates a justified premium from a marketing markup, so the published record places it at the center of any cost judgment. Unusually cheap GHK-Cu sold with no verification carries genuine risk: it may be underdosed, impure, mislabeled, or degraded, so the apparent saving can buy a product that delivers little active peptide or introduces contaminants.
A higher GHK-Cu price is justified when it buys verified purity, stability, and accurate dosing documented by a current batch-specific certificate of analysis, but not when the premium reflects only luxury packaging and brand positioning over identical or inferior material.
Educational use only. This article describes what the published scientific and clinical literature reports about GHK-Cu. It is not medical advice, and it does not recommend, prescribe, or tell anyone to use anything described here. The regulatory status shown at the top of this page reflects what the record showed on the date given there and can change. mdpep.com does not sell any substance described here, does not endorse human use of it, and does not direct anyone to obtain it.
This is not guidance for your situation. Nothing here accounts for your medical history, your current medications, or anything else specific to you, and none of it should be used to make a decision about your own health.
Affiliate disclosure. Some links on this site are affiliate links, and mdpep.com may earn a commission when they are used. That never affects what is written here, it is not an endorsement of any vendor, and it is not a statement that anything described on this page is available to buy.
Every claim here ties to a named primary source and a date, written as plain documentation with nothing for sale. That is how MD PEP covers the whole peptide market.
